Literature DB >> 15776573

Antibody-mediated activation of a defective beta-D-galactosidase. II. Immunological relationship between the normal and the defective enzyme.

F Celada, J Ellis, K Bodlund, B Rotman.   

Abstract

Two closely related protein antigens were used to study immunogenic competition. Namely, normal beta-D-galactosidase of Escherichia coli (Z) and a genetically defective beta-D-galactosidase (AMEF) which seems to differ from the normal in one amino acid substitution. A unique characteristic of this pair of antigens is that, although they are indistinguishable in precipitation and absorption tests with antibodies, the enzymatic activity of AMEF is specifically increased several-hundredfold in the presence of antibodies directed against Z. The following results show that Z and AMEF also differ in their immunogenic ability: (a) antibodies directed against Z activated AMEF; antibodies directed against AMEF did not activate, but competed specifically with activating antibodies. (b) Animals immunized with AMEF failed to produce activating antibodies when they were subsequently challenged with Z, although the presence of some cells primed to produce activating antibodies could be demonstrated by adoptive transfer. (c) Animals preimmunized with Z were stimulated in their production of activating antibodies by AMEF challenge, although not as efficiently as with Z. A model explaining these observations by competition for the immunogenic site among antigen-sensitive cells carrying cross-reacting receptors is presented.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 15776573      PMCID: PMC2139083          DOI: 10.1084/jem.134.3.751

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  MECHANISM OF ENZYME INHIBITION BY ANTIBODY. A STUDY OF THE NEUTRALIZATION OF RIBONUCLEASE.

Authors:  B CINADER; K J LAFFERTY
Journal:  Immunology       Date:  1964-07       Impact factor: 7.397

2.  INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE.

Authors:  N A MITCHISON
Journal:  Proc R Soc Lond B Biol Sci       Date:  1964-12-15

3.  PURIFICATION, COMPOSITION, AND MOLECULAR WEIGHT OF THE BETA-GALACTOSIDASE OF ESCHERICHIA COLI K12.

Authors:  G R CRAVEN; E STEERS; C B ANFINSEN
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

4.  Recombination studies of lactose nonfermenting mutants of Escherichia coli K-12.

Authors:  A COOK; J LEDERBERG
Journal:  Genetics       Date:  1962-10       Impact factor: 4.562

5.  Penicillinase-antipenicillinase.

Authors:  M R POLLOCK
Journal:  Ann N Y Acad Sci       Date:  1963-05-08       Impact factor: 5.691

6.  Genetic analysis of mutants producing defective beta-galactosidase which can be activated by specific antibodie.

Authors:  F Melchers
Journal:  Mol Gen Genet       Date:  1970

7.  Antibody-mediated activation of a defective beta-D-galactosidase extracted from an Escherichia coli mutant.

Authors:  M B Rotman; F Celada
Journal:  Proc Natl Acad Sci U S A       Date:  1968-06       Impact factor: 11.205

8.  Degeneracy in the secondary immune response: stimulation of antibody formation by cross-reacting antigens.

Authors:  H N Eisen; J R Little; L A Steiner; E S Simms; W Gray
Journal:  Isr J Med Sci       Date:  1969 May-Jun

9.  Quantitative studies of the adoptive immunological memory in mice. I. An age-dependent barrier to syngeneic transplantation.

Authors:  F Celada
Journal:  J Exp Med       Date:  1966-07-01       Impact factor: 14.307

10.  Detection of simultaneous antibody synthesis in plasma cells and specialized lymphocytes in rabbit lymph nodes.

Authors:  S Avrameas; E H Leduc
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  11 in total

1.  In vitro antibody response to a distinct antigenic determinant of Escherichia coli beta-D-galactosidase. Effect of antigen dosage and co-cultivation of lymph node fragments on peak titres and duration of antibody synthesis.

Authors:  A J Macario; E Conway de Macario
Journal:  Immunology       Date:  1974-07       Impact factor: 7.397

2.  An immunoenzymatic system to study in vitro immune responses. Synthesis of antibodies directed toward different -D-galactosidase determinants in lymph node fragment cultures.

Authors:  A J Macario; E Conway de Macario; F Celada
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

3.  Antibody-mediated activation of a defective beta-D-galactosidase: dimeric form of the activatable mutant enzyme.

Authors:  E Conway de Macario; J Ellis; R Guzman; B Rotman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

4.  Stabilizing effect of anti-normal erythrocyte catalase antibody on the labile catalase variant present in Swiss-type acatalasemia.

Authors:  E Shipira; Y Ben-Yoseph; H Aebi
Journal:  Experientia       Date:  1973-11-15

5.  Competitive enzyme immunoassay for detection of complement-fixing antibodies in diagnostic virology.

Authors:  S Giunta; G Groppa
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

6.  Extracellular esterases of group A streptococci.

Authors:  S Hayano; A Tanaka
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

7.  Activation of beta-galactosidase by monoclonal antibodies.

Authors:  R J Duncan; J Hewitt; P D Weston
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

8.  Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids.

Authors:  R S Accolla; R Cina; E Montesoro; F Celada
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.

Authors:  F Celada; C Cambiaggi; J Maccari; S Burastero; T Gregory; E Patzer; J Porter; C McDanal; T Matthews
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

Review 10.  Antibody-mediated enzyme formation: Its legacy at age fifty-four.

Authors:  Roberto Strom; Franco Celada
Journal:  J Mol Recognit       Date:  2021-10-24       Impact factor: 2.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.